መነሻ › አትሪያል ፊብሪሌሽን › አላባማ
በአላባማ ለአትሪያል ፊብሪሌሽን የሚደረጉ ክሊኒካዊ ጥናቶች
ለአትሪያል ፊብሪሌሽን የሚደረጉ 11 ጥናቶች በአላባማ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በአላባማ ውስጥ ያሉ ከተሞች
Official study text (English)
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Advanced Cardiovascular, Alexander City
- SEC Clinical Research, Dothan
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- SEC Clinical Research, Dothan
- Eastern Shore Research Institute, Fairhope
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07175428A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Grandview Medical Center, Birmingham
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07527299Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- University of Alabama at Birmingham, Birmingham
- Grandview Medical Center, Birmingham
- Cardiology Associates of Mobile, Mobile
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT04088071Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- SEC Clinical Research, Dothan
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07430956Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
- University of Alabama at Birmingham (UAB) Hospital, Birmingham
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ31 ጁላይ 2026 · NCT07298473Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
- Grandview, Birmingham
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁላይ 2026 · NCT06784466Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 1040, Birmingham
- Anthos Investigational site 9939, Birmingham
- Anthos Investigative Site 9947, Birmingham
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 65 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ጁላይ 2026 · NCT05712200Tracking Results of Ablations to Combat AF Registry Generation 2
- Huntsville Hospital, Huntsville
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT05111015Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- University of Alabama Hospital, Birmingham
- University of South Alabama University Hospital, Mobile
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሜይ 2026 · NCT03907046The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
- Arrhythmia Institute at Grandview, Birmingham
- Mobile Cardiology Associates, Mobile
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ31 ኦክቶ 2025 · NCT06324201ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።